SGLT‐2 inhibitors vs sulphonylureas
Hypoglycaemic episodes a) Non‐serious hypoglycaemia
It is very uncertain whether SGLT‐2 inhibitors changes hypoglycaemic episodes a) Non‐serious hypoglycaemia compared with sulphonylureas (very low certainty).
1 finding from 1 review
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes onlyRR 0.28 [0.1, 0.79]1 study · 110 participantsVery low